February 4-8, 2013

Tufts CSDD Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation

Celebrating 40 years: Drug Development Training for Tomorrow's Innovation Leaders

Tufts CSDD’s highly acclaimed, five-day Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation provides advanced instruction in practical and technical problem-solving in the areas of clinical pharmacology, drug development & clinical trial strategies, biopharmaceutical development, drug safety, and new drug regulation.

The course will be hosted in the Ballroom of the famed Ritz-Carlton Hotel, overlooking historic Boston Common in the heart of downtown Boston. Thousands of professionals in drug development are alumni of this prestigious course, where top speakers and specialized development simulations provide you with a comprehensive, CME-accredited experience. Join our mailing list to stay updated on when early-bird registration opens, as well as other details for the 2013 Postgraduate Course.

The 2013 materials will be released soon, however you can browse the Agenda and Brochure from our 2012 course.

Who should attend the course:

• Physicians, pharmacists, marketing executives, clinical researchers, nurses, analysts, investors and any professional working with or in the research-based drug industry.  
• Professionals looking to begin work in the pharma or biotech sectors, and are seeking comprehensive and foundational industry knowledge and training.
• Individuals employed by regulatory agencies, academic institutions, outsourcing providers, consultancy firms, niche service providers, and other organizations involved in the research, development, and regulation of pharmaceutical products. 

Course Goals:

The goal of the CSDD Postgraduate course is to provide a broad and basic overview of topics related to pharmaceutical development and regulation for professionals involved in pharmaceutical and biopharmaceutical innovation.  Educational Objectives for CME - at the conclusion of the activity, participants will be able to:

 

• Clinical Pharmacology: Integrate the relevant pharmacology, pharmacokinetics, and statistics related to drug development and the nature of evidence required for proof of efficacy and safety.  
• Drug Development and Clinical Trials: Using a case-study approach identify and solve practical, theoretical, and technical problems in human drug studies, and analyze an experimental design for a new drug candidate. 
• Regulation: Evaluate the science, laws, and regulations pertaining to the development and review of new drug products in the USA, Europe, Japan and other pharmaceutical markets.

Tufts CSDD Postgrad Course has enriched hundreds of companies and institutions, including:

• From Industry: PhRMA, Biogen Idec, Merck and Co., Inc., Pfizer, Genzyme, Novartis, Eli LIlly, Parexel Corporation, Sunovion Pharmaceuticals, Genentech, Inc., Shire Pharmaceuticals, Novo Norodisk, Vertex Pharmaceuticals, Bristol-Myers Squibb, Bayer Healthcare, Millennium-Takeda Pharmaceuticals, Roche-Genentech,  Sanofi,  Purdue Pharma, Endo Pharmaceuticals and others.
• From Academia:  Harvard University, Columbia University, University of South Wales, Northeastern University, Tufts Medical School and others 
• From Government and Regulatory: Walter Reed Army Institute of Research, Consumer Healthcare Products Association, The US Department of Defense, the FDA and others.